Astorg, a private equity firm, agreed to acquire Hamilton Thorne, a provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies, for $282m. "Hamilton Thorne believes the proposed Transaction will provide compelling and certain value at an attractive premium to our shareholders. Astorg, with a proven track record of investing in MedTech companies with a focus on growth and innovation, will be a strong partner and trusted steward of Hamilton Thorne as the Company enters this next phase," David Wolf, Hamilton Thorne Executive Chair.